双歧杆菌三联活菌对小鼠非酒精性脂肪肝模型中肠道微生物组的影响  

Effect of Bifidobacterium trisporus on Intestinal Microbiota in the Mouse Model of Non-alcoholic Fatty Liver Disease

作　　者：李春 周琼 梅聪 黄洁杰 王毅鹏 周松兰 郑倩 唐哲 LI Chun;ZHOU Qiong;MEI Cong;HUANG Jie jie;WANG Yi peng;ZHOU Song lan;ZHENG Qian;TANG Zhe(Dept.of Endocrinology,Kunming Yan'an Hospital,Kunming Yunnan 650051,China)

机构地区：[1]昆明市延安医院内分泌科,云南昆明650051

出　　处：《昆明医科大学学报》2023年第10期77-82,共6页Journal of Kunming Medical University

基　　金：云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目(2018FE001-277)。

摘　　要：目的探究双歧杆菌三联活菌在小鼠NAFLD模型中的疗效和对肠道微生物组的影响。方法使用C57BL/6J小鼠分为3个实验组别,对照组(n=10):小鼠使用普通饮食饲养;NAFLD模型组(n=10):使用高脂饮食饲养;双歧杆菌组(n=10):使用NAFLD模型小鼠并给予双歧杆菌三联活菌治疗。在实验结束时间点对不同组小鼠肝脏石蜡切片进行HE染色观察病理变化。采用16S rRNA基因测序技术完成对各组小鼠肠道菌群的检测,并进行生物信息学分析。结果与对照组相比,NAFLD小鼠肝脏脂肪累积增加,脂滴增多,细胞肥大,并且血清谷丙转氨酶(ALT)水平增加(P<0.0001);经双歧杆菌治疗后,NAFLD小鼠肝脏脂肪积累减少并且血清ALT水平降低(P<0.0001)。肠道微生物群分析在3个组别中鉴定出共有菌种348种。微生物功能分析显示,双歧杆菌组肠道微生物代谢功能水平介于对照组和NAFLD组之间;双歧杆菌治疗能改变NAFLD模型中特定肠道微生物的丰度变化,并且这些肠道微生物可能参与了谷胱甘肽代谢、嘌呤代谢和鞘脂代谢等途径调节机体的代谢功能。结论双歧杆菌三联活菌在小鼠模型中可能通过调节肠道微生物组的功能改善NAFLD,并且双歧杆菌三联活菌有改善机体脂代谢紊乱的潜力。Objective To investigate the therapeutic effects of probiotics containing Bifidobacterium on a mouse model of non-alcoholic fatty liver disease(NAFLD)and its impact on the gut microbiota.Methods C57BL/6J mice were divided into three experimental groups.The control group(n=10)of mice was fed a normal diet,the NAFLD model group(n=10)was fed a high-fat diet,and the probiotics group(n=10)was given Bifidobacteriumtrisporus treatment while using NAFLD model mice.HE staining was performed on paraffin sections of mouse liver from different groups at the end of the experiment to observe pathological changes.The 16S rRNA gene sequencing technique was used to detect the gut microbiota in each group of mice,followed by bioinformatics analysis.Results Compared with the control group,NAFLD mice showed increased accumulation of liver fat,increased number of lipid droplets,enlarged cells,and increased levels of serum alanine aminotransferase(ALT)(P<0.0001).After treatment with Bifidobacteriumtrisporus,the accumulation of liver fat in NAFLD mice decreased and serum ALT levels decreased(P<0.0001).Microbiota analysis of the intestinal tract identified 348 common species of microorganisms in the three groups.Functional analysis of the microbiota showed that the metabolic function of the intestinal microbiota in the Bifidobacterium group was intermediate between the control group and the NAFLD group;Bifidobacterium treatment was able to alter the abundance of specific intestinal microorganisms in the NAFLD model,and these intestinal microorganisms may be involved in the regulation of metabolic function pathways such as glutathione metabolism,purine metabolism,and sphingolipid metabolism in the body.Conclusion Bifidobacterium may improve NAFLD by regulating the function of the intestinal microbiota in a mouse model,and it has the potential to improve disordered lipid metabolism in the body.

关 键 词：非酒精性脂肪性肝(NAFLD) 宏基因组 双歧杆菌三联活菌 高脂饮食 

分 类 号：R589.2[医药卫生—内分泌]